{
  "content": "Of note, amiodarone is associated with safety concerns such as hemodynamic instability, sinus bradycardia, and QT interval prolongation compared to placebo.4., 5., 6., 7. There is also the issue of amiodarone-induced pulmonary toxicity and hepatitis as dreaded and anticipated problems despite their low estimated overall risks of 2% and 3%, respectively.8 Despite this, the PAPABEAR trial found no evidence of an association between excessive sinus bradycardia, hemodynamic deterioration, and adult respiratory distress syndrome following short-term amiodarone therapy when used as POAF prophylaxis.9",
  "source": "https://www.sciencedirect.com/science/article/pii/S0147956323002157",
  "chunk_id": "2fd65ab7-71c6-433e-ba16-4abce1f6b5b7",
  "similarity_score": 0.4009001851081848,
  "query": "amiodarone adverse effects thyroid pulmonary toxicity beta-blockers safety hypotension bradycardia",
  "rank": 29,
  "title": "Combination prophylactic amiodarone with beta-blockers versus beta-blockers in atrial fibrillation after cardiac surgery: A systematic-review and meta-analysis",
  "authors": "Edgar Theodore Polintan, Reejeen Monsalve, Rajiv Hans Menghrajani, Kym Yves Sirilan, Sandeep Samethadka Nayak, Peter Abdelmaseeh, Gabriel Patarroyo-Aponte, Kevin Bryan Lo, Sourbha S. Dani",
  "year": "2023",
  "journal": "Heart & Lung",
  "reference": "Polintan, E. T., Monsalve, R., Menghrajani, R. H., Sirilan, K. Y., Nayak, S. S., Abdelmaseeh, P., Patarroyo-Aponte, G., Lo, K. B., & Dani, S. S. (2023). Combination prophylactic amiodarone with beta-blockers versus beta-blockers in atrial fibrillation after cardiac surgery: A systematic-review and meta-analysis. Heart & Lung, 62, 256-263. https://doi.org/10.1016/j.hrtlng.2023.08.005",
  "doi": "10.1016/j.hrtlng.2023.08.005",
  "chunk_index": 10,
  "total_chunks": 31,
  "retrieved_at": "2025-07-24T22:33:29.466586"
}